In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties

Executive Summary

IN an effort to forge earlier and stronger ties to venture-backed biotechs, the new Merck Research Venture Fund illustrates the lure -- and the limitations -- of strategic pharma-VC relationships. Merck has endowed the MRVF with $250 million and the fund will make a series of investments in life science venture capital firms around the globe. Simultaneously it has also staked a second fund, the Global Health Innovation Fund, with an additional $250 million to invest in later-stage companies outside of the drug area.
Advertisement

Related Content

Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition
Eli Lilly's Open Source Approach To Early Stage Research
CMEA Ventures Into Development, But Not Tied To Lilly As Expected
Sanofi Reworks R&D To Tackle Risk, Meet Unmet Need
Sanofi Reworks R&D To Tackle Risk, Meet Unmet Need
BioPontis Aims To Bridge "Valley Of Death"
Lilly's Evolving Corporate Venture Model
At Merck, Business Development As Usual?
At Merck, Business Development As Usual?
Corporate VC Adds a Business Development Flavor

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel